1 / 19
文档名称:

盐酸二甲双胍口服液说明书(英文).pdf

格式:pdf   大小:325KB   页数:19页
下载后只包含 1 个 PDF 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

盐酸二甲双胍口服液说明书(英文).pdf

上传人:rovend 2021/7/6 文件大小:325 KB

下载得到文件列表

盐酸二甲双胍口服液说明书(英文).pdf

文档介绍

文档介绍:RIOMET®

(metformin hydrochloride oral solution)

Rx only

DESCRIPTION
RIOMET (metformin hydrochloride oral solution) is an oral antihyperglycemic drug used in the
management of type 2 diabetes. Metformin hydrochloride, USP (N,N-dimethylimidodicarbonimidic
diamide hydrochloride) is not chemically or pharmacologically related to any other classes of
oral antihyperglycemic agents. The structural formula is as shown:

Metformin hydrochloride, USP is a white crystalline powder with a molecular formula of
C4H11N5•HCl and a molecular weight of . Metformin hydrochloride, USP g is soluble
in 20 mL of water. The pKa of metformin is . The pH of a 1% aqueous solution of metformin
hydrochloride is .
RIOMET contains 500 mg of metformin hydrochloride per 5 mL and the following inactive
ingredients: Cherry flavor, hydrochloric acid, potassium bicarbonate, purified water, saccharin
calcium, and xylitol.
CLINICAL PHARMACOLOGY
Mechanism of Action
Metformin is an antihyperglycemic agent which improves glucose tolerance in patients with type
2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacologic mechanisms
of action are different from other classes of oral antihyperglycemic agents. Metformin decreases
hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin
sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylureas,
metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal
subjects (except in special circumstances, see PRECAUTIONS) and does not cause
hyperinsulinemia. With metformin therapy, insulin